James E. Muntz

976 total citations · 1 hit paper
18 papers, 751 citations indexed

About

James E. Muntz is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, James E. Muntz has authored 18 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Internal Medicine, 14 papers in Cardiology and Cardiovascular Medicine and 8 papers in Surgery. Recurrent topics in James E. Muntz's work include Venous Thromboembolism Diagnosis and Management (16 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Acute Myocardial Infarction Research (6 papers). James E. Muntz is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (16 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Acute Myocardial Infarction Research (6 papers). James E. Muntz collaborates with scholars based in United States and Canada. James E. Muntz's co-authors include Michael H. Huo, Bruce L. Davidson, Janet Schnee, Jay R. Lieberman, Richard J. Friedman, Gary E. Raskob, M L Clements, Charles W. Francis, Philip C. Comp and Stefan Hantel and has published in prestigious journals such as Blood, The American Journal of Surgery and The Journal of Arthroplasty.

In The Last Decade

James E. Muntz

18 papers receiving 718 citations

Hit Papers

Oral Thrombin Inhibitor Dabigatran Etexilate vs North Ame... 2008 2026 2014 2020 2008 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James E. Muntz United States 10 682 598 201 59 59 18 751
A. Planès France 10 653 1.0× 496 0.8× 335 1.7× 88 1.5× 75 1.3× 23 760
Eric Neuhart France 7 285 0.4× 426 0.7× 128 0.6× 50 0.8× 44 0.7× 13 525
H Decousus France 6 577 0.8× 380 0.6× 246 1.2× 107 1.8× 86 1.5× 15 660
Sara Jane Wessinger United States 10 343 0.5× 209 0.3× 323 1.6× 89 1.5× 18 0.3× 13 532
Luise Tittl Germany 16 771 1.1× 1.0k 1.7× 114 0.6× 23 0.4× 137 2.3× 40 1.2k
Jim Douketis Canada 8 421 0.6× 374 0.6× 90 0.4× 15 0.3× 101 1.7× 12 568
Michel Bellaud France 6 422 0.6× 328 0.5× 199 1.0× 62 1.1× 27 0.5× 8 470
Joanne McGinnis Canada 6 293 0.4× 275 0.5× 111 0.6× 25 0.4× 80 1.4× 7 395
M.J. Kovacs Canada 4 325 0.5× 326 0.5× 82 0.4× 27 0.5× 35 0.6× 5 411
Pierre Legalery France 8 206 0.3× 334 0.6× 168 0.8× 40 0.7× 15 0.3× 10 482

Countries citing papers authored by James E. Muntz

Since Specialization
Citations

This map shows the geographic impact of James E. Muntz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Muntz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Muntz more than expected).

Fields of papers citing papers by James E. Muntz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Muntz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Muntz. The network helps show where James E. Muntz may publish in the future.

Co-authorship network of co-authors of James E. Muntz

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Muntz. A scholar is included among the top collaborators of James E. Muntz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Muntz. James E. Muntz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yang, Tianrui, et al.. (2019). Direct oral anticoagulants versus aspirin for venous thromboembolism prophylaxis after orthopedic surgery. American Journal of Health-System Pharmacy. 76(Supplement_2). S55–S60. 6 indexed citations
2.
Wanat, Matthew A., et al.. (2015). Evaluation and Pharmacokinetics of Treatment Dose Enoxaparin in Hospitalized Patients With Morbid Obesity. Clinical and Applied Thrombosis/Hemostasis. 21(6). 513–520. 26 indexed citations
3.
Muntz, James E.. (2010). Duration of deep vein thrombosis prophylaxis in the surgical patient and its relation to quality issues. The American Journal of Surgery. 200(3). 413–421. 9 indexed citations
4.
Muntz, James E. & Franklin A. Michota. (2009). Prevention and management of venous thromboembolism in the surgical patient: options by surgery type and individual patient risk factors. The American Journal of Surgery. 199(1). S11–S20. 30 indexed citations
5.
Huo, Michael H. & James E. Muntz. (2009). Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: A review. Clinical Therapeutics. 31(6). 1129–1141. 57 indexed citations
6.
Muntz, James E.. (2009). Thromboprophylaxis in orthopedic surgery: how long is long enough?. PubMed. 38(8). 394–401. 12 indexed citations
7.
Ginsberg, Jeffrey S., Bruce L. Davidson, Philip C. Comp, et al.. (2008). Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery. The Journal of Arthroplasty. 24(1). 1–9. 490 indexed citations breakdown →
8.
Muntz, James E., et al.. (2007). Factors associated with thromboprophylaxis for orthopedic patients and their impact on outcome.. PubMed. 36(4). 193–7. 1 indexed citations
10.
Sullivan, Sean D., Bruce L. Davidson, Susan R. Kahn, et al.. (2004). A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism. PharmacoEconomics. 22(9). 605–620. 29 indexed citations
11.
Muntz, James E., et al.. (2004). Major bleeding rates after prophylaxis against venous thromboembolism: Systematic review, meta-analysis, and cost implications. International Journal of Technology Assessment in Health Care. 20(4). 405–414. 27 indexed citations
12.
Muntz, James E., et al.. (2004). Safety syringes can reduce the risk of needlestick injury in venous thromboembolism prophylaxis.. PubMed. 13(1). 15–9. 6 indexed citations
13.
Muntz, James E.. (2003). The Risk of Venous Thromboembolism in Non-Large-Joint Surgeries. Orthopedics. 26(2). s237–42. 7 indexed citations
14.
Kwong, Louis M. & James E. Muntz. (2002). Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy, and safety.. PubMed. 31(11 Suppl). 16–20. 17 indexed citations
15.
Muntz, James E.. (2000). Deep vein thrombosis and pulmonary embolism in the perioperative patient.. PubMed. 6(20 Suppl). S1045–52. 6 indexed citations
16.
Muntz, James E.. (2000). Prevention of thromboembolic complications in the rehabilitation center: diagnostic and risk factor stratification tools.. PubMed. 79(5 Suppl). S17–21. 3 indexed citations
17.
Muntz, James E.. (1997). Perioperative DVT and pulmonary embolism. Diagnosis, management, and treatment.. PubMed. 16(2 Suppl). 25–9, 65. 1 indexed citations
18.
Muntz, James E.. (1997). Diagnosis, Management, and Treatment. Orthopaedic Nursing. 16(Supplement). 25???29–25???29. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026